Anticoagulation in COVID-19: a review of current literature and guidelines
B Narasimhan, M Lorente-Ros… - Hospital …, 2021 - Taylor & Francis
Severe acute respiratory syndrome coronavirus 2 infections are associated with greater risk
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …
Anticoagulant treatment in COVID-19: a narrative review
V Carfora, G Spiniello, R Ricciolino, M Di Mauro… - Journal of thrombosis …, 2021 - Springer
Abstract The actual Coronavirus Disease (COVID 19) pandemic is due to Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), a member of the coronavirus family …
respiratory syndrome coronavirus 2 (SARS-CoV-2), a member of the coronavirus family …
Anticoagulation for COVID-19 patients: a bird's-eye view
F Kreidieh, S Temraz - Clinical and Applied Thrombosis …, 2021 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19) is a systemic disease that can be life-threatening
involving immune and inflammatory responses, and that can result in potentially lethal …
involving immune and inflammatory responses, and that can result in potentially lethal …
Management of thrombotic complications in COVID-19: an update
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV‑2), is now a global pandemic. This virus primarily …
syndrome coronavirus 2 (SARS-CoV‑2), is now a global pandemic. This virus primarily …
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
GD Barnes, A Burnett, A Allen, M Blumenstein… - Journal of thrombosis …, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a viral infection that can, in severe cases,
result in cytokine storm, systemic inflammatory response and coagulopathy that is prognostic …
result in cytokine storm, systemic inflammatory response and coagulopathy that is prognostic …
Anticoagulant therapy in COVID‐19: A narrative review
Z Mohseni Afshar, A Tavakoli Pirzaman… - Clinical and …, 2023 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), can manifest itself in several ways, including …
syndrome coronavirus 2 (SARS‐CoV‐2), can manifest itself in several ways, including …
Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy
Introduction The first patients with Coronavirus disease 2019 (COVID-19) emerged at the
end of 2019. This novel viral infection demonstrated unique features that include …
end of 2019. This novel viral infection demonstrated unique features that include …
A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population
KC Poh, VYJ Tay, SH Lin, HL Chee… - Singapore Medical …, 2022 - journals.lww.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has placed an immense
burden on healthcare systems worldwide. There is intensive research targeted at better …
burden on healthcare systems worldwide. There is intensive research targeted at better …
Anticoagulation in COVID-19: a systematic review, meta-analysis, and rapid guidance from Mayo Clinic
RD McBane II, VDT Roldan, AS Niven, RK Pruthi… - Mayo Clinic …, 2020 - Elsevier
A higher risk of thrombosis has been described as a prominent feature of coronavirus
disease 2019 (COVID-19). This systematic review synthesizes current data on thrombosis …
disease 2019 (COVID-19). This systematic review synthesizes current data on thrombosis …
Thromboembolic disease in COVID-19 patients: a brief narrative review
S Mondal, AL Quintili, K Karamchandani… - Journal of intensive care, 2020 - Springer
Abstract Corona virus 2 (SARS-CoV2/Severe Acute Respiratory Syndrome Corona Virus 2)
infection has emerged as a global health crisis. Incidence of thromboembolic disease is …
infection has emerged as a global health crisis. Incidence of thromboembolic disease is …